Baseline cd44v6-positive circulating tumor cells to predict first-

HIGHLIGHTS

• who: Top from the Department of Molecular Medicine, Liquid Biopsy Unit, Sapienza University of Rome, Rome, Italy have published the Article: Baseline CD44v6-positive circulating tumor cells to predict first-, in the Journal: (JOURNAL) of July/09,/2009
• what: Third, despite the aim of this study was to correlate CD44v6-positive CTC and response to first-line regimen, a longer follow up time, which is in course, will allow the authors to correlate CD44v-positive CTC with PFS and overall survival (OS).
• how: The authors conducted a pilot study to evaluate the prognostic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.